Jeena Sikho Lifecare Limited
All news and filings related to Jeena Sikho Lifecare Limited.
View all news & filings- Low impact
Jeena Sikho Lifecare Limited Announces Publication of Case Studies in Medical Journals
Jeena Sikho Lifecare Limited announced the publication of multiple case studies and reports in medical journals like IJAHR and JAIMS. These studies showcase the company's research in Ayurvedic management of various conditions including CKD, hypertension, and infertility. The publications are available on the company's website.
Read the summary - Low impact
JSLL: Promoters Declare No Encumbrance on Shares for FY26
Jeena Sikho Lifecare Limited promoters, including Manish Grover, declared no encumbrance on their shares for FY26. As of March 31, 2026, no shares held by promoters or promoter groups were pledged. This confirms adherence to SEBI takeover regulations.
Read the summary - Medium impact
Jeena Sikho Lifecare Sells Land for ₹24 Crore
Jeena Sikho Lifecare Limited's Board approved the sale of 48 Bigha of non-operational land for ₹24 Crore to Tresco Realty Group LLP. The transaction, approved on May 8, 2026, does not impact business operations and is not a related party transaction. Completion is subject to specific conditions.
Read the summary - Low impact
Jeena Sikho Lifecare Sells Land for ₹24 Crore
Jeena Sikho Lifecare Limited approved the sale of approximately 48 Bigha of land in Patiala, Punjab, to Tresco Realty Group LLP. The aggregate consideration for the sale is ₹24 crore. The sale is not expected to impact the company's business operations as the land is non-operational.
Read the summary - Low impact
Jeena Sikho Lifecare Limited Notifies Non-Applicability of Large Corporate Framework
Jeena Sikho Lifecare Limited confirmed it is not a Large Corporate as per SEBI criteria. This applies to the financial year ended March 31, 2026. The company submitted necessary details as per SEBI circulars.
Read the summary - Medium impact
Jeena Sikho Lifecare's Noida Hospital Receives NABH Accreditation
Jeena Sikho Lifecare Limited's Noida Hospital has received NABH accreditation for its Panchakarma services. The certificate is valid until March 09, 2029. This accreditation highlights the hospital's commitment to quality healthcare delivery and patient safety.
Read the summary - Medium impact
JSLL Signs Strategic MOU with Sat Kartar Life Limited for Healthcare Collaboration
Jeena Sikho Lifecare Limited (JSLL) signed a strategic MOU with Sat Kartar Life Limited to integrate patient acquisition with healthcare infrastructure. JSLL will pay 15% revenue share for OPD/IPD cases post-payment. The collaboration aims to enhance efficiency and patient outcomes. The MOU is valid for three years.
Read the summary - Low impact
JSLL Files Certificate Under SEBI Regulations for Quarter Ended March 31, 2026
Jeena Sikho Lifecare Limited (JSLL) has submitted a certificate under SEBI (Depositories and Participants Regulations), 2018. The certificate covers the quarter and year ended March 31, 2026, and was issued by the company's Registrar and Share Transfer Agent.
Read the summary - Low impact
Jeena Sikho Lifecare: Trading Window Closed for Designated Persons from April 1, 2026
Jeena Sikho Lifecare Limited will close its trading window for designated persons and relatives from April 1, 2026. The window will reopen 48 hours after the announcement of audited financial results for the quarter and financial year ending March 31, 2026. The date for the board meeting to approve results will be intimated later.
Read the summary - Low impact
Jeena Sikho Lifecare Publishes Case Studies on Ayurvedic Treatments
Jeena Sikho Lifecare Limited announced the publication of three academic case studies and reports in the International Journal of Advanced Research. These publications focus on Ayurvedic management of chronic liver disease, chronic kidney disease, and prostatomegaly, showcasing the company's research and clinical practices.
Read the summary - Low impact
Jeena Sikho Lifecare to Meet Institutional Investors on March 23
Jeena Sikho Lifecare Limited will hold a physical group meeting with institutional investors on March 23, 2026, at Trident, BKC, Mumbai. The meeting, organized by DAM Capital, will be attended by MD Manish Grover and Dr. Ish Sharma. No unpublished price-sensitive information will be disclosed.
Read the summary - Low impact
Jeena Sikho Lifecare Amends Insider Trading Code
Jeena Sikho Lifecare Limited's Board of Directors approved amendments to its Code of Fair Disclosure and Insider Trading Policy on March 9, 2026. The updated code will be available on the company's investor website.
Read the summary - Low impact
Jeena Sikho Lifecare to Participate in Arihant Capital's Bharat Connect Conference
Jeena Sikho Lifecare Limited will attend the Arihant Capital Bharat Connect Conference - Rising Stars 2026. The virtual group meeting is scheduled for March 11, 2026, at 12:00 Noon. Company representatives including the Managing Director and CFO will participate. No unpublished price-sensitive information will be disclosed.
Read the summary - Low impact
Jeena Sikho Lifecare Publishes 6 Case Studies on Ayurvedic Treatments
Jeena Sikho Lifecare Limited has published six case studies and reports in the International Journal of Advanced Research and the Journal of Ayurveda and Integrated Medical Sciences. The publications highlight the company's commitment to Ayurvedic research and evidence-based clinical practices, covering treatments for liver disease, kidney disease, and diabetes.
Read the summary - Medium impact
Jeena Sikho Lifecare's Dehradun Hospital Receives NABH Accreditation
Jeena Sikho Lifecare Limited's Dehradun Hospital has been awarded NABH Accreditation for Panchakarma services. The accreditation is valid until January 5, 2029. This signifies adherence to quality healthcare standards.
Read the summary - Medium impact
Jeena Sikho Lifecare to Establish New 150-Bed Hospital Unit in Ahmedabad
Jeena Sikho Lifecare Limited is establishing a new 150-bed hospital unit in Ahmedabad, Gujarat. The estimated investment is ₹1.5 Crore, covering an area of 1,60,000 Sq. Ft. Operations are expected to commence within 6 months.
Read the summary - High impact
Jeena Sikho Lifecare Q3 FY26 Earnings Call Transcript Released
Jeena Sikho Lifecare reported Q3 FY26 results with operational income at ₹221.7 Cr (up 92% YoY) and EBITDA at ₹100.8 Cr (up 240% YoY). PAT was ₹66.7 Cr (up 400% YoY). The company is expanding its bed capacity and launching new health products and a health card. International expansion is underway in UAE, Kazakhstan, and Nepal.
Read the summary - Medium impact
Jeena Sikho Lifecare: Board Approves Q3 FY26 Unaudited Financial Results
Jeena Sikho Lifecare Limited's Board approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31st, 2025. The limited review reports were also approved. The Board meeting took place on February 7th, 2026.
Read the summary - Low impact
Jeena Sikho Lifecare Submits Q3 FY26 Earnings Call Audio Recording
Jeena Sikho Lifecare Limited has made the audio recording of its Q3 FY 2025-26 earnings conference call available. The call, held on February 9, 2026, discussed financial results for the quarter and nine months ended December 31, 2025. The recording can be accessed on the company's website.
Read the summary - Low impact
Jeena Sikho Lifecare Q3FY26 Unaudited Results Approved
Jeena Sikho Lifecare Limited's Board approved unaudited standalone and consolidated financial results for the quarter and nine months ending December 31, 2025. The results were approved on February 7, 2026, and published on February 9, 2026.
Read the summary - High impact
Jeena Sikho Lifecare Q3FY26 Investor Presentation: Revenue Up 92% YoY
Jeena Sikho Lifecare's Q3 FY26 investor presentation shows a 92% YoY revenue increase to ₹221.66 crore. EBITDA margins remained at 45%. The company plans to launch a Health Card and has over 475 beds under development. Patient volumes and product sales are driving growth.
Read the summary - Medium impact
Jeena Sikho Lifecare Limited Announces Q3 FY26 Unaudited Financial Results
Jeena Sikho Lifecare Limited's Board approved unaudited standalone and consolidated financial results for Q3 FY26 and the nine months ended December 31st, 2025. Limited review reports were also presented. The board meeting was held on February 7th, 2026.
Read the summary - Medium impact
Jeena Sikho Lifecare Approves Q3 FY26 Unaudited Standalone & Consolidated Results
Jeena Sikho Lifecare Limited's Board approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31st, 2025. The Board meeting was held on February 7th, 2026.
Read the summary - Medium impact
Jeena Sikho Lifecare Commences Operations of Two New Hospitals
Jeena Sikho Lifecare Limited has commenced operations of two new hospitals. One hospital is located in Siliguri, West Bengal, and the other in Bhagalpur, Bihar. Both facilities began operations on February 03, 2026.
Read the summary - Low impact
Jeena Sikho Lifecare to Participate in Nuvama 21st India Conference on Feb 10
Jeena Sikho Lifecare Limited will participate in the Nuvama 21st India Conference on February 10, 2026, in Mumbai. The company will interact with investors and analysts based on publicly available information.
Read the summary - Low impact
Jeena Sikho Lifecare to Host Q3 FY26 Earnings Call on Feb 9, 2026
Jeena Sikho Lifecare will host an Earnings Conference Call on February 9, 2026, at 3:30 PM IST to discuss Q3 and 9MFY26 operational and financial performance. Management speakers include MD Manish Grover and CFO Nanak Chand.
Read the summary - Medium impact
Jeena Sikho Lifecare: Case Report on Ayurvedic Cancer Resolution Published
Jeena Sikho Lifecare announced the publication of a case report in the "Ayush Journal of Integrative Oncology." The report details a one-year disease-free resolution of recurrent lymphadenopathy in a breast cancer survivor through Ayurvedic treatment. The publication highlights the company's commitment to advancing Ayurvedic research.
Read the summary - Medium impact
JSLL Approves Loan Agreement of AED 7.53 Million to Wholly Owned Subsidiary
Jeena Sikho Lifecare Limited approved an unsecured loan of AED 7.53 million to its wholly owned subsidiary, Jeena Sikho International LLC. The loan will be disbursed in two tranches with an interest rate of 8.5% per annum for a tenure of five years. The company also noted and paid fines for past regulatory non-compliance.
Read the summary - Medium impact
Jeena Sikho Lifecare to acquire 51% stake in UAE's Back to Roots Ayurveda for AED 1.53M
Jeena Sikho Lifecare, through its subsidiary, will acquire a 51% stake in UAE-based Back to Roots Ayurveda by Dr. Shyam LLC. The acquisition, valued at AED 1,530,000 (approx. ₹3.5 crore), aims to expand JSLL's footprint in the Ayurveda and wellness sector internationally. The deal is expected to conclude in 2-3 months.
Read the summary - Medium impact
Jeena Sikho Lifecare Partners with Theryco Healthcare for Amazon Sales
Jeena Sikho Lifecare Limited has partnered with Theryco Healthcare Solutions Private Limited to manage sales of its products on Amazon. This agreement aims to enhance digital distribution and product availability.
Read the summary - Low impact
Jeena Sikho Lifecare Publishes Research on Ayurvedic Management of T2DM
Jeena Sikho Lifecare Limited announced the publication of a case study on Ayurvedic management of Type 2 Diabetes Mellitus. The study detailed significant clinical improvements in a patient, including reduced blood glucose and normalized HbA1c. It also highlights the effectiveness of Ayurvedic interventions for T2DM with pancreatic insufficiency and dyslipidemia.
Read the summary - Low impact
Jeena Sikho Lifecare: Publishes 9 Case Studies and Reports on Ayurvedic Treatments
Jeena Sikho Lifecare Limited (JSLL) has published nine case studies and reports authored by its medical professionals. These publications highlight the company's commitment to advancing Ayurvedic research and evidence-based clinical practices across various health conditions.
Read the summary - Low impact
JSLL Submits SEBI Compliance Certificate for Q3 FY26
Jeena Sikho Lifecare Limited submitted a SEBI compliance certificate for the quarter ended December 31, 2025. The certificate was issued by the company's Registrar and Share Transfer Agent, Skyline Financial Services Private Limited.
Read the summary - Low impact
Jeena Sikho Lifecare Publishes Case Studies in International Journals
Jeena Sikho Lifecare Limited announced the publication of multiple case studies and reports in international journals. The publications feature research by the company's medical professionals on Ayurvedic treatments for various conditions, including PCOS, kidney disease, and colon ulcers, highlighting the company's commitment to research and evidence-based practices.
Read the summary - Medium impact
Jeena Sikho Lifecare's Sanganer Hospital Receives NABH Accreditation
Jeena Sikho Lifecare Limited's Sanganer Hospital in Rajasthan has received NABH accreditation for its Panchakarma services. The accreditation is valid until November 10, 2028, signifying adherence to quality healthcare standards.
Read the summary - Low impact
Jeena Sikho Lifecare Grants 2,18,875 Stock Options to 1,176 Employees
Jeena Sikho Lifecare Limited approved the grant of 2,18,875 Employee Stock Options to 1,176 employees under its ESOP 2025 scheme. The exercise price is ₹2 per option, and each option converts to one equity share of ₹2 face value. The grant aims for employee motivation and long-term value creation.
Read the summary - Low impact
JSLL Grants 2.18 Lakh Stock Options to 1,176 Employees
Jeena Sikho Lifecare Limited has granted 2,18,875 Employee Stock Options to 1,176 employees under its ESOP 2025 scheme. The exercise price is ₹2 per option, with each option convertible to one equity share of ₹2 face value. The grant aims for employee motivation and long-term value creation.
Read the summary - Low impact
Jeena Sikho Lifecare Publishes Case Studies on Ayurvedic CKD Treatment
Jeena Sikho Lifecare Limited published case studies on Ayurvedic treatment for Chronic Kidney Disease (CKD). A case study on a 56-year-old patient showed improvements in blood urea, serum creatinine, and uric acid levels. The company highlights its commitment to Ayurvedic research and evidence-based practices.
Read the summary - Low impact
Jeena Sikho Lifecare: Trading Window Closed from Jan 1, 2026 for Q4 FY26 Results
Jeena Sikho Lifecare Limited will close its trading window for designated persons and relatives from January 1, 2026. The window will reopen 48 hours after the declaration of Unaudited Financial Results for the quarter ending December 31, 2025.
Read the summary - Medium impact
Jeena Sikho Lifecare Expands Niva Bupa Empanelment with New Hospital Units
Jeena Sikho Lifecare Limited has signed an addendum to its empanelment arrangement with Niva Bupa Health Insurance Company Limited. This expands the network to include additional hospital units. The company confirmed the addendum is in the ordinary course of business and does not involve related party transactions.
Read the summary - Medium impact
Jeena Sikho Lifecare Empanelled with Medsave Health Insurance TPA
Jeena Sikho Lifecare Limited has been empanelled with Medsave Health Insurance TPA Limited as a network healthcare provider. This allows the company to offer cashless Ayurveda Panchkarma treatments to Medsave's insured beneficiaries. The empanelment is effective from 26 December 2025 and covers multiple hospital locations.
Read the summary - Medium impact
Jeena Sikho Lifecare Empanelled Under MPPGCL Cashless Health Scheme
Jeena Sikho Lifecare Limited's Ayurveda Panchkarma Hospital has been empanelled under the Madhya Pradesh Power Company Contributory Cashless Health Scheme (MPPCHS). This allows the company to offer cashless Ayurveda treatments to MPPGCL employees and their families.
Read the summary - Medium impact
Jeena Sikho Lifecare Empanelled with Air India for Ayurveda Panchkarma Treatment
Jeena Sikho Lifecare Limited has been empanelled with Air India to provide cashless Ayurveda Panchkarma treatment to Air India employees and beneficiaries. The empanelment is effective from December 26, 2025, and covers multiple hospital locations.
Read the summary - Low impact
Jeena Sikho Lifecare Appoints Forvis Mazars LLP as Internal Auditor
Jeena Sikho Lifecare Limited has appointed M/s. Forvis Mazars LLP as its Internal Auditor for FY 2025-26. This follows the resignation of M/s. Deepak K Garg & Associates due to other professional commitments. The appointment was approved by the Board of Directors on December 23, 2025.
Read the summary - Low impact
JSLL Appoints Forvis Mazars LLP as Internal Auditor, Accepts Resignation of Deepak K Garg & Associates
Jeena Sikho Lifecare Limited appointed Forvis Mazars LLP as its Internal Auditor for FY 2025-26. This follows the acceptance of the resignation of the previous auditor, M/s Deepak K Garg & Associates. The appointment and resignation were effective from December 23, 2025. The Board meeting concluded at 7:15 PM.
Read the summary - Low impact
Jeena Sikho Lifecare Publishes 4 Case Studies on Ayurvedic Treatments
Jeena Sikho Lifecare Limited announced the publication of four case studies in a global journal, authored by its medical professionals. One study details a 7-day Ayurvedic treatment for a 48-year-old female with Stage V CKD, hypertension, and diabetes, showing significant symptom relief and improved biochemical markers.
Read the summary - Medium impact
Jeena Sikho Lifecare Publishes Case Studies on Ayurvedic Therapies for Chronic Kidney Disease
Jeena Sikho Lifecare Limited announced the publication of six case studies in medical journals. These studies, authored by company medical professionals including the Managing Director, focus on the effectiveness of Ayurvedic therapies in managing Chronic Kidney Disease (CKD). The publications aim to advance Ayurvedic research and promote evidence-based practices.
Read the summary - Medium impact
JSLL Receives In-Principle Approval for ESOP Listing
Jeena Sikho Lifecare Limited received in-principle approval from NSE and BSE for listing up to 2,50,000 equity shares under the 'Jeena Sikho Employees Stock Option Scheme, 2025'.
Read the summary - Low impact
JSLL Announces Publication of Case Studies in Pharmaceutical Journal
Jeena Sikho Lifecare Limited announces the publication of case studies in the "World Journal of Pharmaceutical and Life Sciences", authored by its medical professionals.
Read the summary - Low impact
JSLL Announces Publication of Research Articles and Case Studies
JSLL announces publication of research articles and case studies authored by its medical professionals, showcasing commitment to Ayurvedic research and clinical practices.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio